Lansinoh Laboratories announces new VP marketing, senior brand manager
ALEXANDRIA, Va. Lansinoh Laboratories on Tuesday announced the addition of two new members of the company’s marketing family. Jennifer Moyer joins Lansinoh as VP marketing, bringing more than 19 years of marketing experience in the consumer, mother and baby spheres. And Mary Gordon joins the company as senior brand manager.
Both are new positions created to support the company’s expanding product line and marketing efforts.
“Lansinoh is ushering in a period of aggressive growth,” stated Gary Downing, CEO of Lansinoh Laboratories. “Over the past year, we’ve dramatically expanded our product line with several new additions for new and breastfeeding moms, including Lansinoh Diaper Rash Ointment, LatchAssist, and our acquisition of the Soothies Gel Pad brand. And we have even more exciting products in the pipeline to be released in coming months. Now more than ever we need a broad array of highly skilled marketers to maximize the success of this new and expansive purple product line.”
As VP marketing, Moyer will coordinate all North American marketing activities while leading the company’s team of brand marketing professionals. She will report to Downing. Prior to joining Lansinoh, Moyer was as an independent consultant to the company, working closely with Lansinoh’s previous director of Marketing, Kira Wood, who recently left the company to raise her children full-time. Since joining the Lansinoh family in 2008, Moyer has made significant contributions to marketing efforts through development of an improved corporate web site, to launch this summer, and enhanced communication with consumers through various social media channels.
Earlier, Moyer served as VP of brand management firm Kanter International from 2005 to 2008. She was responsible for consulting, research based strategy and marketing for brands including Mohawk Flooring, Herman Miller and Everlast.
As the company’s senior brand manager, Mary Gordon will oversee several key groups of the Lansinoh product line by developing and executing marketing strategies. She will report directly to Moyer.
Previously, Gordon worked extensively in brand management. Most recently, she served as brand manager at Dial Corporation from 2007 to 2009, working on the Combat and RightGuard brands.
NCPA, Roche Diagnostic team up with new online diabetic resource
ALEXANDRIA, Va. In an alliance with Roche Diagnostic, the National Community Pharmacists Association is giving its independent pharmacy members a new tool to expand their presence in the crucial market for diabetic care services and supplies.
NCPA has launched a new, online resource, dubbed the “Diabetes Supply Center,” through the organization’s Pharmacist e-Link. The Web site is designed to provide pharmacists with the information needed to serve patients with diabetes more effectively and make diabetic supplies a viable part of their business, according to the group.
The site helps pharmacists navigate the regulatory process for competitive bidding, accreditation or surety bonds, NCPA noted Monday. It also provides business tools, articles catering to pharmacists, news updates, expert opinion forums and a regular newsletter.
“Many independent community pharmacies are caught between the need to serve their patients with diabetes and navigating an excessive amount of government regulation and costs if they want to continue selling medical supplies such as diabetes testing strips,” said NCPA president Holly Whitcomb Henry. “NCPA is proud to partner with Roche Diagnostic to help community pharmacies better confront all of these challenges through the wide array of information found at the Diabetes Supply Center on Pharmacist e-Link.”
Added Luc Vierstraete, Head of Roche Diagnostic Care North America, ““The role of pharmacists continues to grow and evolve and Roche recognizes their important role in the health care community.”
An American Diabetes Association study in 2007 found 17.5 million people diagnosed with diabetes in America at a cost of $174 billion. The average patient spends approximately $2,500 at community pharmacies for diabetes medications and supplies.
Pure Biosciences’ SDC-based disinfectants meet CDC standards for swine flu care
SAN DIEGO Pure Bioscience on Sunday confirmed that all EPA-registered SDC-based disinfectants, branded Axen30, meet the recommendations by the United States Centers for Disease Control for infection control for care of patients with confirmed or swine flu in both home and healthcare settings.
“Pure’s SDC-based disinfectant is effective against both human and avian influenza A, and our distributors across the nation are poised and ready to respond to the current outbreak,” stated Pure president and CEO Michael Krall. “Should the current outbreak become pandemic, Pure has the manufacturing capability to react not only to the needs in the U.S. but also abroad to supply our powerful disinfectant to governments, healthcare institutions and consumers seeking to effectively stem the spread of swine flu.”
Axen30 is sold through a variety of distributors under more than a dozen private label brands, the company stated. Pure’s SDC-based disinfectants have been registered by the EPA specifically for use on children’s toys, cribs, high chairs and other sensitive areas of the home as well as for use on hard surfaces in multitudes of environments, including hospitals, schools and offices.
Guidance published by the CDC on April 24 for infection control in healthcare settings advises that “disinfection strategies used during influenza seasons can be applied to the environmental management of swine influenza.” Additional guidance published on April 25 for infection control in the home recommends keeping “surfaces (especially bedside tables, surfaces in the bathroom, and toys for children) clean by wiping them down with a household disinfectant according to directions on the product label.”